⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 1, 2024Open Access

Supplementary Figure S1 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer

Joris van de Haar Joanne M. Mankor Karlijn Hummelink Kim Monkhorst Egbert F. Smit Lodewyk F.A. Wessels Edwin Cuppen Joachim G.J.V. Aerts Emile E. Voest

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

The cTMB and outcome of ICB monotherapy in the discovery cohort.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Haar et al. (2024) studied this question.

synapsesocial.com/papers/68e712deb6db64358768c073 https://doi.org/10.1158/1078-0432.25515838

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024
2Supplementary Figure S1 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024
3Supplementary Figure S3 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024
4Supplementary Figure S3 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024
5Supplementary Figure S3 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024

More related papers

Supplementary Figure S2 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024
Supplementary Figure S2 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024
Supplementary Figure S2 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer2024